Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Technology
Study Phase : Discovery
Sponsor : Astellas Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Details : The research agreement aims to promote the utilization of differentiated cells and tissues derived from human induced pluripotent stem cells (iPS cells) and to create innovative medical solutions.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 04, 2023
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Technology
Highest Development Status : Discovery
Sponsor : Astellas Pharma
Deal Size : Undisclosed
Deal Type : Agreement